Showing 41-50 of 328 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Targeting RNLS for Type 1 Diabetes Therapy | Joslin Diabetes Center Inc. | Peng Yi | Cures | 01-June-2025 to 31-May-2028 | $1.349.997,00 |
| T1D Global Access Grand Strategy | Clinton Health Access Initiative (CHAI) | Nine Steensma | Mission | 01-August-2024 to 30-September-2025 | $1.179.001,50 |
| Expanding Access to T1D Care through the PEN-Plus Strategy | The Brigham and Women’s Hospital, Inc. | Gene Bukhman | Mission | 01-August-2024 to 31-July-2027 | $5.999.961,29 |
| Project Equity | The Sonia Nabeta Foundation | Vivian Nabeta | Mission | 01-May-2024 to 30-April-2026 | $245.172,00 |
| Closing the T1D diagnosis gap in Ethiopia, Ghana and Nigeria | Clinton Health Access Initiative (CHAI) | Margaret Prust | Mission | 01-September-2023 to 31-August-2026 | $1.702.076,57 |
| Convergency, LLC Consulting Agreement | Convergency | Larry Soler | Transportfolio | 01-March-2025 to 28-February-2026 | $60.000,00 |
| Developing Fit-For-Purpose Patient-reported Outcomes (PRO) Measure(s) in Type 1 Diabetes | Vector Psychometric Group | R. J. Wirth | Cures | 01-February-2025 to 31-March-2027 | $797.087,00 |
| Consulting Support for Continuity Biosciences | Biologics Consulting Group, Inc. | Diana Colleluori | Cures | 01-April-2025 to 31-August-2025 | $63.475,00 |
| Market Analysis of Insulin Products Utilized by Patients With T1D & Pervasiveness of Insulin Caps | Milliman | Rebecca Smith | Transportfolio | 01-January-2025 to 01-October-2025 | $545.000,00 |
| An AI-driven bioelectronics system to accelerate SC-islet maturation | Trustees of the University of Pennsylvania | Juan Alvarez | Cures | 01-April-2025 to 31-March-2026 | $200.000,00 |